For companies such as HRV Pharma out of India, the standardized scale of manufacturing has expanded alongside its ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. The pharmaceutical industry is in the midst of profound ...

More pharma companies are launching direct-to-consumer drug platforms and the rise of these self-pay services could improve ...

Model N’s Michael Grosberg breaks down the accelerated complexity, policy disruption, and data gaps testing manufacturer market access and revenue management strategies. In the debut episode ...

CinRx Pharma’s formula of scouting for promising drug assets and forming new companies around them has produced five “CinCos,” one of which successfully went public and went on to an acquisition by a ...

In my previous column, I discussed how pharmaceutical and medical device companies are adapting their commercial model approaches in critical areas to address growing economic, market and other ...

The Helical virtual AI lab for pharma, an application layer that turns biological foundation models into decision-ready, reproducible in-silico discovery workflows. The $10 million funding will ...

SAN MATEO, Calif.--(BUSINESS WIRE)--Model N (NYSE: MODN), the leader in revenue optimization and compliance today announced new product innovations geared towards the increasingly complex regulatory ...

But as the cost and complexity of drug development increases, the need for alternative sources of capital is becoming ...

We recently compiled a list of the 12 AI Stocks Making Headlines: Latest News and Ratings. In this article, we are going to take a look at where IGC Pharma, Inc. (NYSEAMERICAN:IGC) stands against the ...

Model N has made further enhancements to 340B Vigilance, one of the company’s key products for pharma manufacturers to manage 340B rebates and compliance. New 340B Vigilance enhancements simplify ...